BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 30261199)

  • 1. A systematic review of evidence-based treatments for prurigo nodularis.
    Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
    J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prurigo Nodularis and Its Management.
    Zeidler C; Yosipovitch G; Ständer S
    Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prurigo Nodularis Management.
    Tsianakas A; Zeidler C; Ständer S
    Curr Probl Dermatol; 2016; 50():94-101. PubMed ID: 27578077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prurigo nodularis: a review.
    Lee MR; Shumack S
    Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Prurigo of Nodular Type: A Review.
    Zeidler C; Tsianakas A; Pereira M; Ständer H; Yosipovitch G; Ständer S
    Acta Derm Venereol; 2018 Feb; 98(2):173-179. PubMed ID: 29135018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and Burden of Disease in a Cohort of Patients with Prurigo Nodularis: A Survey-based Study.
    Todberg T; Zachariae C; Skov L
    Acta Derm Venereol; 2020 Apr; 100(8):adv00119. PubMed ID: 32215661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide for the treatment of chronic refractory pruritus.
    Sharma D; Kwatra SG
    J Am Acad Dermatol; 2016 Feb; 74(2):363-9. PubMed ID: 26577510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prurigo nodularis: Pathogenesis and management.
    Williams KA; Huang AH; Belzberg M; Kwatra SG
    J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Neuropathic Itch.
    Rosen JD; Fostini AC; Yosipovitch G
    Dermatol Clin; 2018 Jul; 36(3):213-224. PubMed ID: 29929594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of prurigo nodularis with topical capsaicin.
    Ständer S; Luger T; Metze D
    J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prurigo nodularis of Hyde treated with low-dose thalidomide.
    Orlando A; Renna S; Cottone M
    Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review.
    Ranpariya M; Zaino ML; McCampbell LE; Patel T; Feldman SR
    J Cutan Med Surg; 2024; 28(2):173-177. PubMed ID: 38291823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prurigo nodularis: an update on etiopathogenesis and therapy.
    Fostini AC; Girolomoni G; Tessari G
    J Dermatolog Treat; 2013 Dec; 24(6):458-62. PubMed ID: 23767411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Medication for the Treatment of Prurigo Nodularis-A Systematic Review.
    McCampbell LE; Zaino ML; Ranpariya M; Patel T; Feldman SR
    J Cutan Med Surg; 2023 Nov; 27(6):641-645. PubMed ID: 37987710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of lenalidomide in treating refractory prurigo nodularis.
    Liu H; Gaspari AA; Schleichert R
    J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of prurigo nodularis].
    Zeidler C; Ständer S
    Hautarzt; 2014 Aug; 65(8):709-13. PubMed ID: 25113330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide for the treatment of chronic refractory prurigo nodularis.
    Aguh C; Kwatra SG; He A; Okoye GA
    Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
    Frølunde AS; Wiis MAK; Ben Abdallah H; Elsgaard S; Danielsen AK; Deleuran M; Vestergaard C
    Dermatology; 2022; 238(5):950-960. PubMed ID: 35417906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
    Maurer T; Poncelet A; Berger T
    Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide.
    Lan CC; Lin CL; Wu CS; Chai CY; Chen WT; Chen GS
    J Dermatol; 2007 Apr; 34(4):237-42. PubMed ID: 17352720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.